Mark Aspinall-O'Dea, PhD

Associate Director - Discovery at Charles River

Speaker

First author on several peer-reviewed papers, Mark Aspinall-O’Dea is Associate Director in Biotherapeutics at Charles River. Mark's scientific experience includes 10 years of postdoctoral research in clinical and academic settings, and more than 10 years of commercial experience in the biopharmaceutical field. Mark currently leads a large research team focused on the Retrogenix cell microarray platform and future technology developments.